Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Novel ITK tyrosine kinase inhibitors and their use covered by BMS patent

Aug. 13, 2002

Crucell and NIAID expand Ebola vaccine agreement to include Marburg and Lassa vaccines

Aug. 13, 2002

Adjuvant QS-21 enhances immunogenicity of malaria peptide vaccine

Aug. 6, 2002

Zonagen receives SBIR grant to study adjuvant system

Aug. 5, 2002

Marketing authorization for Triacelluvax withdrawn in E.U.

Aug. 5, 2002

New formulation of Rapamune introduced in U.K.

July 26, 2002

Plexus Vaccine and GlaxoSmithKline sign vaccine research agreement

July 25, 2002

Enrollment completed in phase II/III trial of ABX-CBL in steroid-resistant GVHD

July 24, 2002

New CB2 agonists and their use in autoimmune diseases, etc.

July 16, 2002

Abiogen and Philogen collaborate on hepatitis C and tetanus vaccines

July 16, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...